甘李药业：GZR33注射液Ⅲ期临床试验完成首例受试者给药Available in: 中文2026-04-14T08:47:31.856Z·1 min read♡ 0🔗 Copy link阅读原文：甘李药业：GZR33注射液Ⅲ期临床试验完成首例受试者给药摘要甘李药业：GZR33注射液Ⅲ期临床试验完成首例受试者给药来源本文首发于 36kr。阅读原文：甘李药业：GZR33注射液Ⅲ期临床试验完成首例受试者给药← Previous: [36kr] 李云泽会见美国桥水投资公司创始人瑞·达利欧Next: [36kr] OpenRouter上线100B参数匿名模型Elephant Alpha →Related ArticlesI Watched 18 Hours of Coachella’s Vertical Livestream and All I Got Was This Lousy FOMO2026-04-14T18:17:12.057Z · TechElon Musk grilled by senator over X Money plans2026-04-14T18:17:09.489Z · TechOracle taps Bloom for 2.8 GW of fuel cells to keep datacenter binge going2026-04-14T18:17:03.670Z · TechShow HN: A memory database that forgets, consolidates, and detects contradiction]2026-04-14T18:17:00.911Z · TechModifying FileZilla to Workaround Bambu 3D Printer's FTP Issue]2026-04-14T18:16:58.346Z · TechComments0Post